Mirvie in the news

Read about our progress creating a personalized window into pregnancy health

In the news

Read about our progress creating a personalized window into pregnancy health

Find Mirvie in
the news

Read about our progress creating a personalized window into pregnancy health

Featured Story

Predicting preeclampsia from a blood test holds promise for pregnancy complications

January 5, 2022

New research published Wednesday in Nature shows how RNA molecules sequenced from a single blood sample could predict preeclampsia months before symptoms appear, holding promise for detecting and treating this and other pregnancy complications before they cause harm.

Predicting preeclampsia from a blood test holds promise for pregnancy complications

January 5, 2022

New research published Wednesday in Nature shows how RNA molecules sequenced from a single blood sample could predict preeclampsia months before symptoms appear, holding promise for detecting and treating this and other pregnancy complications before they cause harm.

Media Releases

Study Published in Nature Shows Mirvie Can Predict Pregnancy Complications Months Before They Happen Using New, Proprietary RNA Platform

January 5, 2022

Mirvie, a pioneer in predicting unexpected pregnancy complications, today announced the publication of a study in Nature proving the proprietary Mirvie RNA platform is first to predict unexpected complications by revealing the underlying biology of each pregnancy. The research analyzed the largest and most diverse dataset of maternal transcriptomes to date. The platform opens a new window into pregnancy health for women to act and their doctors to intervene before unexpected complications become a crisis.

Mirvie is redefining pregnancy health by developing the first early detection RNA test to address pregnancy complications which impact 45 million women globally

April 27, 2021

Pregnancy complications affect 45 million women globally each year, five times the rate of cancer incidence. Today there is no reliable way to identify those pregnancies at-risk. The goal of Mirvie’s simple blood test is the early detection of complications such as preterm birth, preeclampsia and gestational diabetes, which has the potential to reduce pregnancy healthcare costs by up to 65%.

Press Coverage

Cell-Free RNA Testing For Pregnancy Complications

Mirvie is developing a revolutionary, cell-free RNA test using a simple blood sample to assess the risk of developing severe pregnancy complications.

Improving Pregnancy Health: How We Can Predict Challenges Sooner

Obstetrics has improved in treating conditions like preterm birth and preeclampsia, but the ability to predict who’s at risk is “ripe for exploration and innovation.”

Meet Mirvie, a Femtech Startup Creating a Blood Test for Early Detection of Pregnancy Complications

Earlier today Mirvie announced it is making rapid progress toward developing a simple, personalized blood test with the potential for early detection of pregnancy complications, such as preterm birth, preeclampsia and gestational diabetes, which affect 1 in 5 women. Currently, there is no reliable way to identify if a mother is at risk for these significant pregnancy complications.…

A former Grail exec and the president of the Chan Zuckerberg Biohub are developing a blood test to help expectant mothers understand the chances of pregnancy complications

With Mirvie, Quake and Jain are attempting to apply liquid biopsy technology more commonly found in oncology centers to pregnancy, a more common but significantly less funded area of research, according to Jain.

Noninvasive blood tests for fetal development predict gestational age and preterm delivery.

Low-cost methods for monitoring fetal development could improve prenatal care, especially in low-resource settings. By measuring the levels of certain placental RNA transcripts in maternal blood…

10 Breakthrough Technologies 2019 – How we’ll invent the future.

by Bill Gates

We asked Gates to choose this year’s list of inventions that will change the world for the better. I was honored when MIT Technology Review invited me to be the first guest curator of its 10 Breakthrough Technologies…

Complications from preterm birth are the leading cause of death worldwide in children under five.

by Bonnie Rochman

Fifteen million babies are born pre­maturely each year. Stephen Quake’s daughter, Zoe, was one of them: she arrived via emergency C-section after Quake and his wife, Athina, made a middle-of-the-night dash to the emergency room, a month before Zoe was due. She spent her first night in an incubator, and her father, a bioengineer then at Caltech, wondered why birth couldn’t be more predictable…

Cell-Free RNA Testing For Pregnancy Complications

Mirvie is developing a revolutionary, cell-free RNA test using a simple blood sample to assess the risk of developing severe pregnancy complications.

Improving Pregnancy Health: How We Can Predict Challenges Sooner

Obstetrics has improved in treating conditions like preterm birth and preeclampsia, but the ability to predict who’s at risk is “ripe for exploration and innovation.”

Meet Mirvie, a Femtech Startup Creating a Blood Test for Early Detection of Pregnancy Complications

Earlier today Mirvie announced it is making rapid progress toward developing a simple, personalized blood test with the potential for early detection of pregnancy complications, such as preterm birth, preeclampsia and gestational diabetes, which affect 1 in 5 women. Currently, there is no reliable way to identify if a mother is at risk for these significant pregnancy complications.…

A former Grail exec and the president of the Chan Zuckerberg Biohub are developing a blood test to help expectant mothers understand the chances of pregnancy complications

With Mirvie, Quake and Jain are attempting to apply liquid biopsy technology more commonly found in oncology centers to pregnancy, a more common but significantly less funded area of research, according to Jain.

Meet Mirvie, a Femtech Startup Creating a Blood Test for Early Detection of Pregnancy Complications

Earlier today Mirvie announced it is making rapid progress toward developing a simple, personalized blood test with the potential for early detection of pregnancy complications, such as preterm birth, preeclampsia and gestational diabetes, which affect 1 in 5 women. Currently, there is no reliable way to identify if a mother is at risk for these significant pregnancy complications.…

Noninvasive blood tests for fetal development predict gestational age and preterm delivery.

Low-cost methods for monitoring fetal development could improve prenatal care, especially in low-resource settings. By measuring the levels of certain placental RNA transcripts in maternal blood…

10 Breakthrough Technologies 2019 – How we’ll invent the future.

by Bill Gates

We asked Gates to choose this year’s list of inventions that will change the world for the better. I was honored when MIT Technology Review invited me to be the first guest curator of its 10 Breakthrough Technologies…

Complications from preterm birth are the leading cause of death worldwide in children under five.

by Bonnie Rochman

Fifteen million babies are born pre­maturely each year. Stephen Quake’s daughter, Zoe, was one of them: she arrived via emergency C-section after Quake and his wife, Athina, made a middle-of-the-night dash to the emergency room, a month before Zoe was due. She spent her first night in an incubator, and her father, a bioengineer then at Caltech, wondered why birth couldn’t be more predictable…

Have questions for us?

Our team is happy to answer them. Use our contact form to reach out and we’ll get back to you soon.